why choose us

First received: March 16, 2023

Clinical Trial: Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase I/II Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

Brief Summary: To determine the safety and efficacy of using the drug azeliragon combined with stereotactic radiosurgery.Specifically, to determine if this combination will lead to improved response in the brain (tumor shrinking in size) and overall tumor control (how long tumor remains controlled).

Read more